Your passport shows your date of birth. Your cells, however, keep a different record.
Two people born in the same year can show radically different biological profiles at 50. One has cells that biologically resemble those of a 42-year-old. The other, those of a 61-year-old. The difference isn't visible to the naked eye. It is written into the epigenome — the layer of molecular regulation that controls gene expression without changing the DNA sequence itself.
Since 2013, the biology of aging has had tools to read that record. They're called epigenetic clocks. Their development is one of the most significant advances of contemporary geroscience.
What is the epigenome, and why does it age?
The epigenome is the set of chemical modifications that regulate gene expression without altering the DNA sequence. It acts as a molecular switching system: some genes are turned on, others silenced, according to epigenetic profiles specific to each cell type. The two best-characterised epigenetic mechanisms are DNA methylation — the addition of a methyl group to specific cytosines, generally associated with gene repression — and histone modifications, which regulate DNA accessibility.
These profiles aren't fixed. Over time, methylation profiles drift in a predictable, reproducible way — following patterns that vary little between individuals of the same chronological age. It is precisely this predictability that made the development of epigenetic clocks possible.
Steve Horvath and the first epigenetic clock
In 2013, biostatistician Steve Horvath published a paper in Genome Biology that would transform geroscience. Analysing DNA methylation profiles across more than 8,000 biological samples covering 51 tissue types, he identified 353 methylation sites whose variations could predict chronological age with an average error of 3.6 years.
The Horvath clock was born. For the first time, it became possible to estimate a tissue's biological age from a simple epigenetic profile — without knowing the person's age. But the most important discovery wasn't the prediction's accuracy. It's what the clock reveals when it diverges from chronological age.
Biological age vs. chronological age: when the clock diverges
In some individuals, the epigenetic clock runs faster than the calendar. This difference — called epigenetic acceleration — is not trivial. Numerous studies have shown that acceleration of the Horvath clock is associated with increased risk of chronic disease and higher all-cause mortality. A 50-year-old whose epigenetic age is estimated at 58 statistically has a health-risk profile closer to that of a 58-year-old. Conversely, a biological age lower than chronological age is associated with better cognitive performance, better functional capacity, and greater longevity.
The next generations of epigenetic clocks
GrimAge, developed by Lu et al. in 2019, incorporates epigenetic markers to directly predict remaining life expectancy. It is to date the epigenetic clock with the highest predictive value for mortality.
DunedinPACE, published by Belsky et al. in eLife in 2022, doesn't measure an instantaneous biological age, but rather the speed at which a person is aging at the time of measurement. It can detect differences in aging pace as early as one's thirties — well before clinical signs appear — and proves particularly valuable for intervention studies, measuring whether a protocol actually slows the pace of biological aging.
The Lu clock (2023), published in Nature Aging, integrates multi-omic data (epigenome, transcriptome, metabolome) to measure biological age at an even higher resolution.
Epigenetic aging may not be irreversible.
What epigenetic clocks have taught us about aging
Epigenetic aging starts early: differences in biological aging pace between individuals are already measurable at 30, long before any clinical manifestation. Lifestyle modulates the epigenetic clock: smoking, obesity, sedentary behaviour and chronic stress accelerate it, while regular physical activity and quality nutrition are associated with a slower epigenetic age.
The sirtuins and NAD+ also modulate the epigenome: the sirtuins SIRT1 and SIRT6, which depend on NAD+ for their activity, are direct regulators of histone modifications and DNA methylation. Their declining activity — partly caused by falling NAD+ — contributes to the epigenetic dysregulation measured by the clocks.
Epigenetic reprogramming: the next frontier
The most spectacular discovery enabled by epigenetic clocks: under certain experimental conditions, the epigenetic age of cells can be rejuvenated. The work of Shinya Yamanaka — 2012 Nobel laureate in Medicine — demonstrated that adult cells could be reprogrammed by activating four transcription factors (Oct4, Sox2, Klf4, c-Myc, the so-called "Yamanaka factors"). This reprogramming resets the epigenetic clock to zero.
More recent research by David Sinclair at Harvard explores partial, transient reprogramming — sufficient to rejuvenate the epigenome without erasing cellular identity. Results in animal models are remarkable. In humans, these approaches remain at the preclinical stage, but they illustrate a fundamental principle: epigenetic aging may not be irreversible.
Implications for precision cellular nutrition
A study by Fitzgerald et al. (Aging, 2021) showed that a programme combining specific diet, physical activity, sleep and targeted supplementation was associated with an average 3.23-year reduction in epigenetic age over 8 weeks in the intervention group. These results open a new perspective: the possibility of objectively measuring whether a precision nutritional intervention, like the one behind Cellular Daily, changes the pace of biological aging.
In conclusion
Epigenetic clocks represent the first quantitative window opened onto an individual's real biological aging — beyond chronological age.
By revealing that the epigenome carries a biological memory of aging, modifiable by environment and lifestyle, they have profoundly changed how geroscience thinks about longevity. No longer as a fate fixed at birth, but as a dynamic biological process — measurable, and partly modulable.
This article is published for informational and educational purposes. It does not constitute medical advice and does not replace consultation with a healthcare professional.
